Radiation-free technology for assessing bone density and quality on the lumbar vertebrae and proximal femur through a revolutionary approach to characterise bone microarchitecture using radio frequency signals acquired during a simple ultrasound scan. The method overcomes all the main limits of DXA (Dual-Energy X-ray Absorptiometry) and QUS (Quantitative Bone Ultrasound).
Prevention, early diagnosis and short-term monitoring
A new era in bone densitometry




Radiation-free
Report on the spot
Portable
Primary care
Why R.E.M.S
FDA-Cleared
The most advanced bone densitometer for bone health assessment for your daily clinical activities.
This innovative ultrasound technology measures bone mineral density at axial sites like the spine and femur without ionising radiation, offering high accuracy, ease of use, and portability. It enables bedside assessments for immobile patients and supports home care. Its radiation-free nature makes it suitable for diverse groups, including paediatric patients, pregnant women, patients at risk of secondary osteoporosis, and patients who have undergone cancer treatments.
Bone Density
Evaluation of Bone Mineral Density at the lumbar vertebrae (L1-L4) and the femoral neck providing all common parameters of the diagnosis of osteoporosis: BMD (g/cm2), T-scores, Z-Score.


Body Composition
Analysis of the distribution of body components providing Body Mass Index (BMI), Body Fat and Basal Metabolism Rate measurement (BMR) during the scan.
Fragility Score
Independent assessment of internal bone structure to evaluate the risk of fracture in 5 years through dedicated statistical and spectral analysis.

Reviews
There are no reviews yet.